Artificial Intelligence: AI To Trawl Medical Data Troves To Identify ‘Cause And Effect’, Sharpen Diagnosis

https://dailyalts.com/wp-content/uploads/2020/02/artificial-intelligence-3382521_1280.jpg

The discovery of new causal links in existing medical data could eliminate many a clinical trial.

The correct diagnosis of a disease depends on the knowledge of which medical conditions cause what symptoms. Similarly, its correct treatment depends on knowing a drug’s effects or those from a change in lifestyle. Therefore, the knowledge of “cause and effect” is essential in the medical world.

However, there is a vast store of data from medical observational studies or randomized controlled trials accumulated over the decades. What if we could deploy an AI algo to scour this data for new illumination on “cause and effect”? Get fresh insight on symptoms and the likely disease?

But a unidimensional examination of correlation inside a single data set (say, obesity and heart disease), or that in another data set (low vitamin D and obesity), will not tell us the answer to the causal relationship between low vitamin D and heart disease.

What’s needed is a multi-dimensional ability – an AI tool to scour for causal nexus across many and different data sets.

Cause and effect: Work by researchers Anish Dhir and Ciarán Lee may be the answer

Dhir and Lee, who work at Babylon Health, a digital health care provider in the UK, have incorporated a technique from quantum cryptography to address the challenge. (Lee also works on machine learning and quantum computing at University College, London.)

Their algorithm can extract the maximum information on cause and effect from multiple data sets that share certain common variables and have been combined for the analysis.

For example, they tested the system on datasets where the causal nexus was already identified, such as measurements of the size and texture of breast tumors. The algo correctly pinpointed the links between the size, texture, and malignancy of the tumors.

Their work has been peer-reviewed. It will be presented at the Association for Advancement of Artificial Intelligence conference in New York this week.

Related Story:     A.I. Algorithms Predict the Likelihood of Breast Cancer                                              

Free Industry News

Subscribe to our free newsletter for updates and news about alternatives investments.

  • This field is for validation purposes and should be left unchanged.


Shape

Latest Alternative Investment News

https://dailyalts.com/wp-content/uploads/2023/12/AMD_headquarters_santa_clara.624da707519a6.jpg
Artificial Intelligence: AMD Takes On Rivals In The AI Chip Sweepstakes
December 7, 2023     Artificial Intelligence, News

Chipmaker AMD (NASDAQ: AMD) has unveiled a range of innovative AI solutions spanning from data centers to personal computers. The AMD Instinct MI300 Series features data center AI accelerators, while…

https://dailyalts.com/wp-content/uploads/2023/12/RHCEU-Inline.jpg
Digital Assets: Robinhood Debuts Crypto Trading On Its App In The EU
December 7, 2023     Digital Assets, FinTech, News

Robinhood (NASDAQ: HOOD) has launched its Crypto app in the European Union (EU), allowing eligible customers to engage in crypto trading with the added incentive of earning Bitcoin rewards. Customers…

https://dailyalts.com/wp-content/uploads/2023/12/Samsung_UK_Samsung_Pay_Lifestyle_0552-revised-Pictogram-23.11.30-1024x744-1.png
FinTech: Samsung Electronics Ties With Mastercard’s Wallet Express
December 7, 2023     FinTech, News

Samsung Electronics (KRX: 005930) and Mastercard (NYSE: MA) have partnered to launch the Wallet Express program, offering banks and card issuers a cost-effective way to expand digital wallet offerings. Through…

https://dailyalts.com/wp-content/uploads/2023/12/Revaia-founders.jpg
Venture Capital: Revaia, Europe’s Biggest Female-Led VC Firm, Racks Up $160M For Second Fund
December 7, 2023     ESG and Sustainability, News, Venture Capital

Revaia, Europe’s largest female-founded venture capital firm, has successfully raised €150 million ($160 million) for its second fund, Revaia Growth II. The funding was secured from sovereign wealth funds, family…